RxAnte
Submit RFI/RFPRxAnte is the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs. The companys patent-pending predictive analytics and decision support solutions turn ordinary claims and clinical data into actionable insights and smart recommendations proven to help health care organizations and the populations they serve use medications more effectively, improve outcomes and lower costs. for more about http://www.rxante.com
Contact Address | 511 Congress St Suite 803Portland ME 4101 United States |
Phone Number | 703.288.0300 | 844.655.6515 |
info@rxante.com | |
Website | https://www.rxante.com/ |
Category | Consumer Experience, Value Based Care |
More Like This

CenseoHealth is changing the way health plans and healthcare organizations interact with their membe...

Explorys was founded in 2009 as an innovation spinoff from Cleveland Clinic. Explorys addresses the...

Healthplans.com believe that finding the right health insurance plan should be easy. Thats why H...

As a leading technology company that provides advanced cloudbased data analytics and data-driven sol...

Enigma Health introduces the first program of its kind thats specifically designed to address a ...

eClinicalWorks® is a privately-held leader in ambulatory healthcare IT solutions. With clients ac...

At Thunderhead we help brands get closer to their customers and prospects by helping them better und...

myNEXUS¢ is a technology driven, connected care management service that manages an individual...

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward A...

At Davis Vision we are working to reframe eye care. For too many people, taking care of their eyes i...

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resour...

APH team members have more than 20 years of industry experience in the essentials: healthcare provid...

The healthcare technology industry is overdue for disruption and innovation. Thats why weve ...